Search

Kimberly R Lockett

Examiner (ID: 6478, Phone: (571)272-2067 , Office: P/2837 )

Most Active Art Unit
2837
Art Unit(s)
2837, 2832, 2107
Total Applications
2779
Issued Applications
2301
Pending Applications
126
Abandoned Applications
351

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7373134 [patent_doc_number] => 20040006775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Screening systems and methods for identifying modulators of xenobiotic matabolism' [patent_app_type] => new [patent_app_number] => 10/380555 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10242 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006775.pdf [firstpage_image] =>[orig_patent_app_number] => 10380555 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/380555
Screening systems and methods for identifying modulators of xenobiotic matabolism Jul 24, 2003 Abandoned
Array ( [id] => 7216189 [patent_doc_number] => 20040071675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Vector system' [patent_app_type] => new [patent_app_number] => 10/429608 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 27264 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10429608 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/429608
Vector system May 4, 2003 Abandoned
Array ( [id] => 7395197 [patent_doc_number] => 20040018178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis' [patent_app_type] => new [patent_app_number] => 10/348359 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10598 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018178.pdf [firstpage_image] =>[orig_patent_app_number] => 10348359 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/348359
Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis Jan 21, 2003 Abandoned
Array ( [id] => 6851005 [patent_doc_number] => 20030143208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Oxidative stress-resistant cell lines and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/337049 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8186 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143208.pdf [firstpage_image] =>[orig_patent_app_number] => 10337049 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/337049
Oxidative stress-resistant cell lines and methods of use thereof Jan 5, 2003 Abandoned
Array ( [id] => 6639355 [patent_doc_number] => 20030212027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Vaccine formulations and methods for immunizing an individual against shed antigen specific B cells' [patent_app_type] => new [patent_app_number] => 10/336210 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13809 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212027.pdf [firstpage_image] =>[orig_patent_app_number] => 10336210 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/336210
Vaccine formulations and methods for immunizing an individual against shed antigen specific B cells Jan 2, 2003 Abandoned
Array ( [id] => 6760736 [patent_doc_number] => 20030124097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Method to improve the safety of gene therapy' [patent_app_type] => new [patent_app_number] => 10/310991 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8355 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124097.pdf [firstpage_image] =>[orig_patent_app_number] => 10310991 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/310991
Method to improve the safety of gene therapy Dec 5, 2002 Abandoned
Array ( [id] => 6669425 [patent_doc_number] => 20030114409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Facilitation of RNA interference' [patent_app_type] => new [patent_app_number] => 10/295809 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14388 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114409.pdf [firstpage_image] =>[orig_patent_app_number] => 10295809 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/295809
Facilitation of RNA interference Nov 14, 2002 Abandoned
Array ( [id] => 6869484 [patent_doc_number] => 20030082173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Lymphocyte surface receptor that binds CAML and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/293816 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26850 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082173.pdf [firstpage_image] =>[orig_patent_app_number] => 10293816 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/293816
Lymphocyte surface receptor that binds CAML and methods of use thereof Nov 11, 2002 Abandoned
Array ( [id] => 6668929 [patent_doc_number] => 20030113913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Method of enhancing self renewal of stem cells and uses thereof' [patent_app_type] => new [patent_app_number] => 10/274054 [patent_app_country] => US [patent_app_date] => 2002-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7191 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113913.pdf [firstpage_image] =>[orig_patent_app_number] => 10274054 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/274054
Method of enhancing self renewal of stem cells and uses thereof Oct 20, 2002 Abandoned
Array ( [id] => 7312763 [patent_doc_number] => 20040033486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'M cell directed vaccines' [patent_app_type] => new [patent_app_number] => 10/169492 [patent_app_country] => US [patent_app_date] => 2002-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11307 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033486.pdf [firstpage_image] =>[orig_patent_app_number] => 10169492 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/169492
M cell directed vaccines Oct 20, 2002 Abandoned
Array ( [id] => 524233 [patent_doc_number] => 07186879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Screening systems and methods for identifying modulators of xenobiotic metabolism' [patent_app_type] => utility [patent_app_number] => 10/268822 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 16707 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186879.pdf [firstpage_image] =>[orig_patent_app_number] => 10268822 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/268822
Screening systems and methods for identifying modulators of xenobiotic metabolism Oct 9, 2002 Issued
Array ( [id] => 7036724 [patent_doc_number] => 20050034183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Non-human animal model for analysis of the original and therapy of organ fibrosis' [patent_app_type] => utility [patent_app_number] => 10/490885 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3402 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20050034183.pdf [firstpage_image] =>[orig_patent_app_number] => 10490885 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/490885
Non-human animal model for analysis of the original and therapy of organ fibrosis Sep 26, 2002 Abandoned
Array ( [id] => 6658027 [patent_doc_number] => 20030078228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Fas Ligand' [patent_app_type] => new [patent_app_number] => 10/252821 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7429 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078228.pdf [firstpage_image] =>[orig_patent_app_number] => 10252821 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/252821
Fas Ligand Sep 23, 2002 Abandoned
10/110731 Lymphocytes, a process for preparing the same and their use in therapeutics Sep 15, 2002 Abandoned
Array ( [id] => 6773835 [patent_doc_number] => 20030017173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Arrestable therapeutic viral agent' [patent_app_type] => new [patent_app_number] => 10/242827 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4006 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017173.pdf [firstpage_image] =>[orig_patent_app_number] => 10242827 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/242827
Arrestable therapeutic viral agent Sep 12, 2002 Abandoned
Array ( [id] => 6698328 [patent_doc_number] => 20030110522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the PSP94 gene' [patent_app_type] => new [patent_app_number] => 10/231773 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14571 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20030110522.pdf [firstpage_image] =>[orig_patent_app_number] => 10231773 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/231773
Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the PSP94 gene Aug 29, 2002 Abandoned
Array ( [id] => 732934 [patent_doc_number] => 07037903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Method for using thymosin β-10 for gene therapy of solid malignant tumors' [patent_app_type] => utility [patent_app_number] => 10/231845 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6239 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037903.pdf [firstpage_image] =>[orig_patent_app_number] => 10231845 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/231845
Method for using thymosin β-10 for gene therapy of solid malignant tumors Aug 29, 2002 Issued
Array ( [id] => 6675000 [patent_doc_number] => 20030060603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Antibodies generated against polypeptide targets expressed from polynucleotide administration' [patent_app_type] => new [patent_app_number] => 10/232777 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10838 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060603.pdf [firstpage_image] =>[orig_patent_app_number] => 10232777 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/232777
Antibodies generated against polypeptide targets expressed from polynucleotide administration Aug 29, 2002 Abandoned
Array ( [id] => 6656559 [patent_doc_number] => 20030009774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Screening systems and methods for identifying modulators of xenobiotic metabolism' [patent_app_type] => new [patent_app_number] => 10/219590 [patent_app_country] => US [patent_app_date] => 2002-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8546 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20030009774.pdf [firstpage_image] =>[orig_patent_app_number] => 10219590 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/219590
Screening systems and methods for identifying modulators of xenobiotic metabolism Aug 14, 2002 Issued
Array ( [id] => 6791570 [patent_doc_number] => 20030086914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Method and device for inducing biological processes by micro-organs' [patent_app_type] => new [patent_app_number] => 10/193136 [patent_app_country] => US [patent_app_date] => 2002-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19851 [patent_no_of_claims] => 167 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086914.pdf [firstpage_image] =>[orig_patent_app_number] => 10193136 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/193136
Method and device for inducing biological processes by micro-organs Jul 11, 2002 Abandoned
Menu